BioCentury
ARTICLE | Company News

Sequenom sales and marketing update

February 11, 2013 8:00 AM UTC

Sequenom said it expanded the range of chromosomal abnormalities reported by the MaterniT21 Plus laboratory-developed test (LDT) to include fetal sex chromosomal aneuploidies, including Turner's synd...